Article Details
Retrieved on: 2025-04-21 13:59:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis. April 21, ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here